Tag: The American Society of Clinical Oncology

Immunotherapy named as the “Advance of the year”

The American Society of Clinical Oncology named immunotherapy as the “Advance of the year”. There were many exciting developments, as you can see from some of our previous posts. There have also been exciting trials with immune therapy in bladder cancer, Hodgkin disease, liver cancer and head and neck cancer. These are especially exciting because… Read more »